Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 10 1997, 2526-2530, Vol 35, No. 10
J Rosenberg, FC Tenover, J Wong, W Jarvis and DJ Vugia
In order to determine whether hospital-based clinical laboratories
conducting active surveillance for vancomycin-resistant enterococci in
three San Francisco Bay area counties (San Francisco, Alameda, and Contra
Costa counties) were accurately reporting vancomycin resistance, five
vancomycin-resistant enterococcal strains and one vancomycin- susceptible
beta-lactamase-producing enterococcus were sent to 31 of 32 (97%)
laboratories conducting surveillance. Each strain was tested by the
laboratory's routine antimicrobial susceptibility testing method. An
Enterococcus faecium strain with high-level resistance to vancomycin (MIC,
512 microg/ml) was correctly reported as resistant by 100% of laboratories;
an E. faecium strain with moderate-level resistance (MIC, 64 microg/ml) was
correctly reported as resistant by 91% of laboratories; two Enterococcus
faecalis strains with low-level resistance (MICs, 32 microg/ml) were
correctly reported as resistant by 97 and 56% of laboratories,
respectively. An Enterococcus gallinarum strain with intrinsic low-level
resistance (MIC, 8 microg/ml) was correctly reported as intermediate by 50%
of laboratories. A beta- lactamase-producing E. faecalis isolate was
correctly identified as susceptible to vancomycin by 100% of laboratories
and as resistant to penicillin and ampicillin by 68 and 44% of
laboratories, respectively; all 23 (74%) laboratories that tested for
beta-lactamase recognized that it was a beta-lactamase producer. This
survey indicated that for clinically significant enterococcal isolates,
laboratories in the San Francisco Bay area have problems in detecting low-
to moderate-level but not high-level vancomycin resistance. Increasing
accuracy of detection and prompt reporting of these isolates and
investigation of cases are the next steps in the battle for control of the
spread of vancomycin resistance.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Are clinical laboratories in California accurately reporting vancomycin- resistant enterococci?
Division of Communicable Disease Control, California Department of Health Services, Berkeley 94704, USA. jrosenbe@hwl.cahwnet.gov
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|